Terms: = Breast cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Treatment
9 results:
1. Identifying Circulating Tumor DNA Mutations Associated with Neoadjuvant Chemotherapy Efficacy in Local Advanced breast cancer.
Wei B; Shan Y; Du Z; Yin C; Zhang Q; Lin H; Zhang G; Song D; Zuo H
Appl Biochem Biotechnol; 2022 Sep; 194(9):3961-3973. PubMed ID: 35579744
[TBL] [Abstract] [Full Text] [Related]
2. Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers.
Domagala P; Hybiak J; Rys J; Byrski T; Cybulski C; Lubinski J
Oncotarget; 2016 Oct; 7(42):68662-68673. PubMed ID: 27626685
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.
Kap EJ; Seibold P; Richter S; Scherer D; Habermann N; Balavarca Y; Jansen L; Becker N; Pfütze K; Popanda O; Hoffmeister M; Ulrich A; Benner A; Ulrich CM; Burwinkel B; Brenner H; Chang-Claude J
Pharmacogenomics J; 2015 Dec; 15(6):505-12. PubMed ID: 25778469
[TBL] [Abstract] [Full Text] [Related]
4. Combined genetic and nutritional risk models of triple negative breast cancer.
Lee E; Levine EA; Franco VI; Allen GO; Gong F; Zhang Y; Hu JJ
Nutr Cancer; 2014; 66(6):955-63. PubMed ID: 25023197
[TBL] [Abstract] [Full Text] [Related]
5. Association of xpc polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
[TBL] [Abstract] [Full Text] [Related]
6. DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells.
Singh KP; Treas J; Tyagi T; Gao W
Cancer Lett; 2012 Mar; 316(1):62-9. PubMed ID: 22082530
[TBL] [Abstract] [Full Text] [Related]
7. [Expression of MMP-9 and VEGF in breast cancer: correlation with other prognostic indicators].
Jobim FC; Schwartsmann G; Xavier NL; Uchoa Dde M; Saciloto M; Chemello N
Rev Bras Ginecol Obstet; 2008 Jun; 30(6):287-93. PubMed ID: 19142506
[TBL] [Abstract] [Full Text] [Related]
8. Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies.
Guillem VM; Collado M; Terol MJ; Calasanz MJ; Esteve J; Gonzalez M; Sanzo C; Nomdedeu J; Bolufer P; Lluch A; Tormo M
Leukemia; 2007 Jul; 21(7):1413-22. PubMed ID: 17476281
[TBL] [Abstract] [Full Text] [Related]
9. Response of human mammary epithelial cells to DNA damage induced by BPDE: involvement of novel regulatory pathways.
Wang A; Gu J; Judson-Kremer K; Powell KL; Mistry H; Simhambhatla P; Aldaz CM; Gaddis S; MacLeod MC
Carcinogenesis; 2003 Feb; 24(2):225-34. PubMed ID: 12584171
[TBL] [Abstract] [Full Text] [Related]
